| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, April 10, 2018 It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral. Left behind will be the 42nd Street building Pfizer has called home since 1961. |
|
|
| This week's sponsor is Biotech Primer. | | | |
Top Stories Of The Week Friday, April 6, 2018 The combination of Incyte’s epacadostat and Merck & Co.’s Keytruda was supposed to pose a major threat to rival Bristol-Myers Squibb’s melanoma franchise—but the data tell a different story. Monday, April 9, 2018 Novartis has struck an $8.7 billion deal to buy AveXis. The move sees newly minted Novartis CEO Vas Narasimhan, M.D., pay a hefty premium to establish the company as a frontrunner in the emerging gene therapy sector. Friday, April 6, 2018 With Takeda weighing a Shire bid, other companies may be taking a hard look at the struggling biotech, too. Credit Suisse analysts have flagged just which companies might make a move and broken down what a deal with each could look like. Tuesday, April 10, 2018 Researchers led by the University of North Carolina scoured the database where pharma companies disclose payments they make to physicians and discovered that oncologists who treat metastatic kidney cancer or chronic myeloid leukemia were more likely to prescribe drugs made by companies that paid them. Friday, April 6, 2018 CVS Health is developing a home dialysis medical device. The pharmacy chain is set to start a clinical trial later this year with a view to securing FDA approval and offering an at-home dialysis service by 2020. Wednesday, April 11, 2018 Just five months after it was approved by the FDA, GlaxoSmithKline's Shingrix has crowded out Merck's Zostavax in the U.S. shingles vaccine field. By mid-March, the new GSK shot had grabbed 90% of the prescriptions tracked by IQVIA, analysts say, as Zostavax's scripts plummeted. Thursday, April 12, 2018 People who have a particular variation in the gene FGF21 tend to crave sweet foods. Now researchers have discovered that the same genetic variation is found in people who naturally have low body fat. This doesn’t mean that everyone with a sweet tooth should feel free to load up on candy bars, however. Thursday, April 12, 2018 At more than $500 million, Sanofi's new Canadian vaccine plant will be one of the largest investments ever by the company in a single facility. And no wonder: The company's vaccine business has been growing at a serious clip. Thursday, April 12, 2018 Biocytogen, a Chinese CRO specialized in gene-targeted animal models and related services, has just closed a $65 million series C round. It plans to expand its footprint in both China and the U.S., including a new R&D operation in Boston. | This week's sponsor is ExL Events. | | | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Veeva Systems Learn how leading companies, from the world’s top pharma to emerging biotechs, are empowering their medical affairs teams. Sponsored by: Veeva Systems To deliver value to key opinion leaders, medical affairs needs to tailor their engagement with deeper analytics and insights. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Sponsored by: WCG Small biopharma companies are conducting almost 50% of the clinical trials in the US today, yet they face unique challenges that large pharma do not. In this paper, we explore some of those challenges, and solutions that can reduce the pressure on small biopharma teams and timelines. Sponsored by: Halo Pharma Why does confidence matter when outsourcing Fixed-Dose Combination products? Download Halo Pharma’s white paper on the importance of product design, technology, and analyticals tools for FDC. Sponsored by: DocuSign Life science companies are experiencing a significant transformation in how they bring new products to market. |
